Diagnos Laboratorium Utama Tbk. vs Rans Entertainmen Indonesia Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Rans Entertainmen Indonesia Tbk trades at Rp202 (market cap 2.57T, 37.7M 24h volume). The key difference: Rans Entertainmen Indonesia Tbk is far larger — about 8.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Rans Entertainmen Indonesia Tbk is more actively traded (37.7M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | RANS | |
|---|---|---|
Market Cap | 316.25B | 2.57T |
Volume | 41.7K | 37.7M |
Lot | 417 | 377K |
Turnover | 9.66M | 7.61B |
Average Price | 231.65 | 201.85 |
Value | 9.66M | 7.61B |
Indicative Equilibrium Price | 230 | 202 |
Indicative Equilibrium Volume | 2.4K | 5.98K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Rans Entertainmen Indonesia Tbk. (the Company) was established with Deed No. 04 on October 18, 2016, which was made before Raden Mas Dendy Subangil S.H., M.Kn., under the name of PT RNR Film Internasional. The Company started its commercial operations in 2018. The Company does not have a parent entity, the ultimate controlling party is Raffi Farid Ahmad as the Companys shareholder.
Read more on RANS →